Abstract Purpose of Review The pathogenesis of dedifferentiated chondrosarcoma is
controversial, and no genetic abnormality has consistently been identified in the disease …

Background Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy
with a poor prognosis. The purpose of this investigation was to describe our treatment and …

BACKGROUND Chordoma and chondrosarcoma of the skull base are frequently
amalgamated because of similar anatomic location, clinical presentation, and radiologic …

BACKGROUND: Dedifferentiated chondrosarcoma has a very poor prognosis. Because of
its rarity, there are few large studies of outcome which might identify potential prognostic …

Background and Objectives Dedifferentiated chondrosarcoma is a rare malignancy with
reported 5‐year overall survival rates ranging from 7% to 24%. The purpose of this …

Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor
survival. There are many confusing issues concerning the imaging feature that can facilitate …

INTRODUCTION: Chondrosarcoma (CS) is a primary malignant bone tumor with
cartilaginous differentiation. The only available treatment is carcinological surgical resection …

Cartilage-forming tumors as a group are the most common primary bone tumors; this is
largely due to the common occurrence of asymptomatic benign lesions such as …

Object Resection of sacral tumors has been shown to improve survival, since the
oncological prognosis is commonly correlated with the extent of local tumor control …